VHVeronka Horber

Veronka Horber

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Veronka Horber has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prevalence, Clinical Features, Neuroimaging, and Genetic Findings in Children With Ataxic Cerebral Palsy in Europe

    by Veronka Horber, Guro L. Andersen, Catherine Arnaud, Javier De La Cruz, Ivana Dakovic, Andra Greitane, Owen Hensey, Kate Himmelmann, Katalin Hollody, Karen Horridge, et al.

    Objective: To report on prevalence, associated impairments, severity and neuroimaging findings in children with ataxic cerebral palsy (CP). Methods: In children coded as having ataxic CP in the Central database of JRC-SCPE (Joint Research Center-Surveillance of Cerebral Palsy in Europe) and born 1980-2010, birth characteristics, severity profiles including associated impairments, neuroimaging patterns and the presence of syndromes were analyzed. Definitions were according to validated SCPE guidelines. Prevalence over time was estimated using Poisson regression. Results: In total, 679 children with ataxic CP were identified in 20 European CP registers. The proportion with ataxic CP was 3.8% and varied from 0% to 12.9%. Prevalence over time showed no significant trend. 70% of children with ataxic CP were able to walk, 40% had severe intellectual impairment and a high impairment index. Children with ataxic CP were mostly born at term (79%) and with normal birth weight (77%). Neuroimaging patterns revealed normal findings in 29%, brain maldevelopments in 28.5% and miscellaneous findings in 23.5% and brain injuries in 19%, according to the SCPE classification. Genetic syndromes were described in 9%. Conclusions: This register-based multicentre study on children with ataxic CP provides a large sample size for the analysis of prevalence, severity and origin of this rare CP subtype. Even with strict inclusion and classification criteria, there is variation between registers on how to deal with this subtype and diagnosis of ataxic CP remains a challenge. Ataxic cerebral palsy differs from other CP subtypes: children with ataxic CP have a disability profile that is more pronounced with respect to cognitive than gross motor dysfunction. They are mostly term born and the origin rarely suggests acquired injuries. In addition to neuroimaging, a comprehensive genetic work-up is particularly recommended for children with this CP type.


  • Open Access

    The Role of Neuroimaging and Genetic Analysis in the Diagnosis of Children With Cerebral Palsy

    by Veronka Horber, Ute Grasshoff, Elodie Sellier, Catherine Arnaud, Ingeborg Krägeloh-Mann, Kate Himmelmann

    Cerebral magnetic resonance imaging (MRI) is considered an important tool in the assessment of a child with cerebral palsy (CP), as it is abnormal in more than 80% of children with CP, disclosing the pathogenic pattern responsible for the neurological condition. MRI, therefore, is recommended as the first diagnostic step after medical history taking and neurological examination. With the advances in genetic diagnostics, the genetic contribution to CP is increasingly discussed, and the question arises about the role of genetic testing in the diagnosis of cerebral palsy. The paper gives an overview on genetic findings reported in CP, which are discussed with respect to the underlying brain pathology according to neuroimaging findings. Surveillance of Cerebral Palsy in Europe (SCPE) classifies neuroimaging findings in CP into five categories, which help to stratify decisions concerning genetic testing. Predominant white and gray matter injuries are by far predominant (accounting for around 50 and 20% of the findings). They are considered to be acquired. Here, predisposing genetic factors may play a role to increase vulnerability (and should especially be considered, when family history is positive and/or causative external factors are missing). In maldevelopments and normal findings (around 11% each), monogenic causes are more likely, and thus, genetic testing is clearly recommended. In the miscellaneous category, the precise nature of the MRI finding has to be considered as it could indicate a genetic origin.


  • Open Access

    Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome

    by Sandra Donkervoort, Payam Mohassel, Lucia Laugwitz, Maha S. Zaki, Erik‐Jan Kamsteeg, Reza Maroofian, Katherine R. Chao, Corien C. Verschuuren‐Bemelmans, Veronka Horber, Annemarie J. M. Fock, et al.

    Synaptotagmins are integral synaptic vesicle membrane proteins that function as calcium sensors and regulate neurotransmitter release at the presynaptic nerve terminal. Synaptotagmin‐2 (SYT2), is the major isoform expressed at the neuromuscular junction. Recently, dominant missense variants in SYT2 have been reported as a rare cause of distal motor neuropathy and myasthenic syndrome, manifesting with stable or slowly progressive distal weakness of variable severity along with presynaptic NMJ impairment. These variants are thought to have a dominant‐negative effect on synaptic vesicle exocytosis, although the precise pathomechanism remains to be elucidated. Here we report seven patients of five families, with biallelic loss of function variants in SYT2, clinically manifesting with a remarkably consistent phenotype of severe congenital onset hypotonia and weakness, with variable degrees of respiratory involvement. Electrodiagnostic findings were consistent with a presynaptic congenital myasthenic syndrome (CMS) in some. Treatment with an acetylcholinesterase inhibitor pursued in three patients showed clinical improvement with increased strength and function. This series further establishes SYT2 as a CMS‐disease gene and expands its clinical and genetic spectrum to include recessive loss‐of‐function variants, manifesting as a severe congenital onset presynaptic CMS with potential treatment implications.


  • Severity of Cerebral Palsy—The Impact of Associated Impairments

    by Veronka Horber, Asma Fares, Mary Jane Platt, Catherine Arnaud, Ingeborg Krägeloh-Mann, Elodie Sellier

    Objective This article describes associated impairments in children with cerebral palsy (CP) and its subtypes. Method Children born between 1990 and 2006 recorded in the Surveillance of Cerebral Palsy in Europe common database were studied. An “impairment index” characterized severity of impairments and their combinations. Results Amongst the 11,015 children analyzed, 56% (n = 5,968) could walk unaided, 54% (4,972) had normal or near-normal intellect (intelligence quotient ≥ 70). Except for ataxic CP, associated impairments were less frequent when walking ability was preserved. The impairment index was low (walking unaided and normal or near-normal intellect) in 30% of cases; 54% (n = 1,637) in unilateral spastic, 24% (n = 79) in ataxic, 18% (n = 913) in bilateral spastic, and 7% (n = 50) in dyskinetic CP. Around 40% had a high impairment index (inability to walk and/or severe intellectual impairment ± additional impairments)—highest in dyskinetic (77%, n = 549) and bilateral spastic CP (54%, n = 2,680). The impairment index varied little in birth weight and gestational age groups. However, significantly fewer cases in the birth weight group ≤ 1,000 g or gestational age group ≤ 27 weeks had a low impairment index compared to the other birth weight and gestational age groups (23 and 24% vs. between 27 and 32%). Conclusion Thirty percent of the children with CP had a low impairment index (they were able to walk unaided and had a normal or near-normal intellect). Severity in CP was strongly associated to subtype, whereas the association was weak with birth weight or gestational age.


  • The Origin of the Cerebral Palsies: Contribution of Population-Based Neuroimaging Data

    by Veronka Horber, Elodie Sellier, Karen Horridge, Gija Rackauskaite, Guro L. Andersen, Daniel Virella, Els Ortibus, Ivana Dakovic, Owen Hensey, Anja Radsel, et al.

    Background Surveillance of cerebral palsy in Europe (SCPE) presents the first population-based results on neuroimaging findings in children with cerebral palsy (CP) using a magnetic resonance imaging classification system (MRICS). Method MRIs of children with CP born between 1999 and 2009 from 18 European countries were analyzed. MRICS identifies patterns of brain pathology according to timing during brain development which was analyzed with respect to CP subtypes and gestational age. Results MRIs or written reports from 3,818 children were available. The main clinical characteristics were similar to the 5,415 without such data. Most frequent was predominant white matter injury (49%), followed by predominant gray matter injury (21%). Maldevelopments were found in 11% of cases. Miscellaneous findings were present in 8.5% and normal findings in 10.6%. MRI patterns of children with unilateral spastic, bilateral spastic, and dyskinetic CP were mainly lesional (77, 71, and 59%, respectively), whereas children with ataxic CP had more maldevelopments, miscellaneous, and normal findings (25, 21, and 32%, respectively). In children born preterm, predominant white matter injury was most prevalent (80% in children born <32 weeks of gestation). Conclusion Analysis of MRI in the European CP database identified CP as a mainly lesional condition on a large population basis, maldevelopments were relatively uncommon. An exception was ataxic CP. Children born preterm mostly presented with a lesion typical for their gestational age (GA) at birth. The decreasing prevalence of CP in this group suggests that progress in perinatal and neonatal medicine may lead to a reduction of these lesions.


  • Clinical features of cerebral palsy in children with symptomatic congenital cytomegalovirus infection

    by Ivana Dakovic, Maria da Graça Andrada, Teresa Folha, David Neubauer, Katalin Hollody, Michaela Honold, Veronka Horber, Vlasta Duranovic, Vlatka Mejaski Bosnjak


  • Prädiktion der Zerebralparese mittels neonataler zerebraler MRT

    by V. Horber, G. van Wezel-Meijler, I. Krägeloh-Mann

    Zerebrale Ultraschalluntersuchungen erlauben eine schnelle und bequeme Diagnostik auf den neonatologischen Stationen. Viele zerebrale Pathologien der Neugeborenen, insbesondere aber der Frühgeborenen sind schnell, zuverlässig und im Verlauf auf seriellen Bildern zu diagnostizieren. Die Ultraschalluntersuchung hat jedoch Grenzen insbesondere in der Beurteilung des Parenchyms und der hinteren Schädelgrube. In solchen Situationen ist die MRT die geeignete Bildgebung. Diese Arbeit gibt eine Übersicht über die mittels MRT darstellbare zerebrale Pathologie bei Früh- und Neugeborenen, zeigt die Möglichkeiten, aber auch die Grenzen der Untersuchung auf und gibt Hinweise für wichtige prädiktive Parameter. Der Schwerpunkt dieses weiten Themas wird auf die Aussagekraft der neonatalen MRT bezüglich der Veränderungen gelegt, die zur Entwicklung einer Zerebralparese (CP) führen können, die insbesondere für Frühgeborene, jedoch auch für Reifgeborene mit belasteter Prä- oder Perinatalperiode eine wesentliche Form der möglichen Behinderung darstellt [1].

  • Eyelid myoclonia with absences (Jeavons syndrome): An unrecognized generalized epileptic syndrome?

    by J Gburek-Augustat, S Ruf, M Döbler-Neumann, V Horber, I Krägeloh-Mann, M Wolff

    Purpose: „Eyelid myoclonia with absences“ (described by Jeavons 1977) is a generalized myoclonic epileptic syndrome with well-defined clinical and EEG characteristics It is probably an underestimated epileptic condition. The hallmarks of Jeavons syndrome are: Eyelid-myoclonia (EM) with or without absences, eye closure-induced spike-wave-discharges in the EEG and photosensitivity In addition, rare tonic-clonic seizures (TCS) may also occur Onset is during childhood with long lasting duration into adulthood To date there are only few clinical data on record Patients and methods: Retrospective analysis (year 2008 and 2009) of all patients (age Results: Six out of 254 patients (2.4%) were diagnosed with Jeavons syndrome (five girls, one boy). Mean age at diagnosis was 9.5 (6–11.5) years. All exhibited EM many years before they were identified as seizures. Two children were wrongly diagnosed as juvenile absence epilepsy. All children showed typical eye closure-induced spike-wave-discharges in the EEG. The duration of spike-wave-discharges was less than 3s in four patients. In two patients duration was between 3 and 6s and specified as absences. TCS were reported in two patients. Medical treatment was introduced in four patients (n=4) because of occurrence of absences (N=2), TCS in 1 patient (N=1) or association with cortical tremor (N=1). VPA (N=2) was effective with respect to absences and TCS, not EM. LEV (N=3), showed an effect in two patients with regard to all seizure types. Conclusion: Jeavons syndrome is a definite epileptic syndrome belonging to the group of generalized epileptic syndromes. Misdiagnoses or late diagnosis are probably frequent. The accurate definition of generalized epileptic syndromes is crucial with respect to the growing genetic insights in epilepsy. In addition, the correct diagnosis has important therapeutic and prognostic implications. LEV seems to have the best effect on EM (Striano, 2008) and should be used as first-line medication in these patients.